Full Text View
Tabular View
No Study Results Posted
Related Studies
LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients
This study has been completed.
Study NCT01167309   Information provided by LEO Pharma

First Received on July 2, 2010.   Last Updated on January 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Secondary Hyperparathyroidism
Additional conditions recognized in this trial
Hyperparathyroidism
Hyperparathyroidism, Secondary
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Kidney Diseases
Parathyroid Diseases
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
LEO 27847
Sponsors listed in this trial
LEO Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services